Methyl 4-hydroxy-3,5-dimethoxybenzoate

Details

Top
Internal ID b992b2ea-9137-4b59-a455-f82fdc34cefe
Taxonomy Benzenoids > Benzene and substituted derivatives > Benzoic acids and derivatives > Hydroxybenzoic acid derivatives > Gallic acid and derivatives
IUPAC Name methyl 4-hydroxy-3,5-dimethoxybenzoate
SMILES (Canonical) COC1=CC(=CC(=C1O)OC)C(=O)OC
SMILES (Isomeric) COC1=CC(=CC(=C1O)OC)C(=O)OC
InChI InChI=1S/C10H12O5/c1-13-7-4-6(10(12)15-3)5-8(14-2)9(7)11/h4-5,11H,1-3H3
InChI Key ZMXJAEGJWHJMGX-UHFFFAOYSA-N
Popularity 153 references in papers

Physical and Chemical Properties

Top
Molecular Formula C10H12O5
Molecular Weight 212.20 g/mol
Exact Mass 212.06847348 g/mol
Topological Polar Surface Area (TPSA) 65.00 Ų
XlogP 1.40
Atomic LogP (AlogP) 1.20
H-Bond Acceptor 5
H-Bond Donor 1
Rotatable Bonds 3

Synonyms

Top
884-35-5
Methyl 4-hydroxy-3,5-dimethoxybenzoate
Methyl 3,5-dimethoxy-4-hydroxybenzoate
Syringic acid methyl ester
Benzoic acid, 4-hydroxy-3,5-dimethoxy-, methyl ester
methyl 4-hydroxy-3,5-dimethoxy-benzoate
W5A196MP8A
CHEBI:45820
MFCD00017199
AI3-36426
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of Methyl 4-hydroxy-3,5-dimethoxybenzoate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9805 98.05%
Caco-2 + 0.7685 76.85%
Blood Brain Barrier - 0.5250 52.50%
Human oral bioavailability + 0.6143 61.43%
Subcellular localzation Mitochondria 0.8742 87.42%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8181 81.81%
OATP1B3 inhibitior + 0.9522 95.22%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.9269 92.69%
P-glycoprotein inhibitior - 0.9425 94.25%
P-glycoprotein substrate - 0.9171 91.71%
CYP3A4 substrate - 0.6326 63.26%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.7812 78.12%
CYP3A4 inhibition - 0.9395 93.95%
CYP2C9 inhibition - 0.9923 99.23%
CYP2C19 inhibition - 0.9459 94.59%
CYP2D6 inhibition - 0.9632 96.32%
CYP1A2 inhibition - 0.9266 92.66%
CYP2C8 inhibition - 0.5970 59.70%
CYP inhibitory promiscuity - 0.9130 91.30%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.7069 70.69%
Carcinogenicity (trinary) Non-required 0.6850 68.50%
Eye corrosion - 0.5624 56.24%
Eye irritation + 0.9706 97.06%
Skin irritation + 0.5149 51.49%
Skin corrosion - 0.9763 97.63%
Ames mutagenesis - 0.8600 86.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6797 67.97%
Micronuclear + 0.5107 51.07%
Hepatotoxicity + 0.5211 52.11%
skin sensitisation - 0.9170 91.70%
Respiratory toxicity - 0.8556 85.56%
Reproductive toxicity + 0.7614 76.14%
Mitochondrial toxicity - 0.8750 87.50%
Nephrotoxicity - 0.7156 71.56%
Acute Oral Toxicity (c) II 0.5994 59.94%
Estrogen receptor binding + 0.5284 52.84%
Androgen receptor binding - 0.7985 79.85%
Thyroid receptor binding - 0.6983 69.83%
Glucocorticoid receptor binding - 0.7238 72.38%
Aromatase binding - 0.6339 63.39%
PPAR gamma - 0.8558 85.58%
Honey bee toxicity - 0.9720 97.20%
Biodegradation + 0.6750 67.50%
Crustacea aquatic toxicity - 0.7800 78.00%
Fish aquatic toxicity + 0.9064 90.64%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 94.59% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 91.05% 96.09%
CHEMBL3060 Q9Y345 Glycine transporter 2 90.09% 99.17%
CHEMBL2535 P11166 Glucose transporter 87.44% 98.75%
CHEMBL4208 P20618 Proteasome component C5 86.83% 90.00%
CHEMBL1293249 Q13887 Kruppel-like factor 5 86.04% 86.33%
CHEMBL1255126 O15151 Protein Mdm4 83.97% 90.20%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 83.46% 96.00%
CHEMBL3864 Q06124 Protein-tyrosine phosphatase 2C 82.56% 94.42%

Cross-Links

Top
PubChem 70164
NPASS NPC277728
LOTUS LTS0079777
wikiData Q27097791